Sequana Medical NV (EBR: SEQUA)

Market Cap	37.27M
Revenue	712.17K
Net Income	-32.56M
Shares Out	40.24M
EPS	-1.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,401
Open	0.956
Previous Close	0.954
Day's Range	0.942 - 0.958
52-Week Range	0.710 - 4.850
Beta	0.84
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 19, 2024

About Sequana Medical NV

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 62
• Stock Exchange: Euronext Brussels
• Ticker Symbol: SEQUA